Psoriasis Drug Now a Potential Candidate to Treat PsA and Uveitis
According to LabioTech, a psoriasis drug developed by biotechnology company Affibody showed promising results in a Phase II clinical trial (AFFIRM-35). This trial, which consisted of 108 participants with…